Trial: 201911155

A Phase 1 Study to Evaluate the Safety and Tolerability of AB680 Combination Therapy in Participants with Gastrointestinal Malignancies

Phase

I (Cancer Control)

Principal Investigator

Lim, Kian-Huat

Disease Site

Metastatic Disease; Pancreas

Learn more about this study at: clinicaltrials.gov